Cancer therapy approved by FDA uses body’s own cells as a ‘living drug’::undefined

  • Bluefruit@lemmy.world
    link
    fedilink
    English
    arrow-up
    16
    ·
    9 months ago

    Iovance Biotherapeutics has priced the therapy, branded Amtagvi, at $515,000 per patient.

    Well thank goodness these kind souls made it so affordable. And im sure it will come down in price after its really proven to be effective right?

    I’m sure the RnD for this was expensive af but ffs man, even with insurance thats probably going to be out of reach for so many people.

    • Candelestine@lemmy.world
      link
      fedilink
      English
      arrow-up
      5
      ·
      9 months ago

      Something, something, technology indistinguishable from magic, something, education funding, something, something.

    • bassomitron@lemmy.world
      link
      fedilink
      English
      arrow-up
      4
      ·
      9 months ago

      To be fair, that is a direct quote taken from one of the researchers:

      “The concept that the FDA has now acknowledged is that you can use a patient’s own cells as a living drug to treat their disease, and that to me is a very exciting step forward,” said Steve Rosenberg, a senior investigator for the National Cancer Institute who has helped pioneer the newly approved therapy since the 1980s.